Able 0 4 0 4 O
to 5 7 5 7 O
provide 8 15 8 15 O
TLFB 16 20 16 20 O
alcohol 21 28 21 28 O
consumption 29 40 29 40 O
information 41 52 41 52 O
for 53 56 53 56 O
the 57 60 57 60 O
90 61 63 61 63 B-upper_bound
- 63 64 63 64 I-upper_bound
day 64 67 64 67 I-upper_bound
period 68 74 68 74 I-upper_bound
prior 75 80 75 80 I-upper_bound
to 81 83 81 83 O
the 84 87 84 87 O
Screen 88 94 88 94 O
Visit 95 100 95 100 O

Able 0 4 101 105 O
to 5 7 106 108 O
read 8 12 109 113 O
and 13 16 114 117 O
understand 17 27 118 128 O
English 28 35 129 136 B-language_fluency
and 36 39 137 140 O
complete 40 48 141 149 O
the 49 52 150 153 O
rating 53 59 154 160 O
scales 60 66 161 167 O
and 67 70 168 171 O
questionnaires 71 85 172 186 O
accurately 86 96 187 197 O
, 96 97 197 198 O
follow 98 104 199 205 O
instructions 105 117 206 218 O
, 117 118 218 219 O
and 119 122 220 223 O
make 123 127 224 228 O
use 128 131 229 232 O
of 132 134 233 235 O
the 135 138 236 239 O
behavioral 139 149 240 250 B-treatment
treatments 150 160 251 261 I-treatment
. 160 161 261 262 O
This 162 166 263 267 O
will 167 171 268 272 O
be 172 174 273 275 O
assessed 175 183 276 284 O
with 184 188 285 289 O
the 189 192 290 293 O
Slosson 193 200 294 301 B-treatment
Oral 201 205 302 306 I-treatment
Reading 206 213 307 314 I-treatment
Test 214 218 315 319 O
- 218 219 319 320 O
Revised 219 226 320 327 O
, 226 227 327 328 O
on 228 230 329 331 O
which 231 236 332 337 O
the 237 240 338 341 O
subject 241 248 342 349 O
must 249 253 350 354 O
demonstrate 254 265 355 366 O
at 266 268 367 369 O
least 269 274 370 375 O
a 275 276 376 377 O
6th 277 280 378 381 B-lower_bound
grade 281 286 382 387 I-lower_bound
reading 287 294 388 395 B-clinical_variable
level 295 300 396 401 I-clinical_variable

Active 0 6 402 408 B-clinical_variable
hepatitis 7 16 409 418 I-clinical_variable
and/or 17 23 419 425 O
serum 24 29 426 431 B-clinical_variable
glutamic 30 38 432 440 I-clinical_variable
oxaloacetic 39 50 441 452 I-clinical_variable
transaminase 51 63 453 465 I-clinical_variable
( 64 65 466 467 I-clinical_variable
SGOT 65 69 467 471 I-clinical_variable
) 69 70 471 472 I-clinical_variable
, 70 71 472 473 O
serum 72 77 474 479 B-clinical_variable
glutamic 78 86 480 488 I-clinical_variable
pyruvic 87 94 489 496 I-clinical_variable
transaminase 95 107 497 509 I-clinical_variable
( 108 109 510 511 I-clinical_variable
SGPT 109 113 511 515 I-clinical_variable
) 113 114 515 516 I-clinical_variable
or 115 117 517 519 O
lactacte 118 126 520 528 B-clinical_variable
dehydrogenase 127 140 529 542 I-clinical_variable
( 141 142 543 544 I-clinical_variable
LDH 142 145 544 547 I-clinical_variable
) 145 146 547 548 I-clinical_variable
> 147 148 549 550 O
3x 149 151 551 553 B-lower_bound
the 152 155 554 557 I-lower_bound
upper 156 161 558 563 I-lower_bound
limit 162 167 564 569 I-lower_bound
of 168 170 570 572 I-lower_bound
normal 171 177 573 579 I-lower_bound

Aged 0 4 580 584 B-age
18 5 7 585 587 B-lower_bound
to 8 10 588 590 O
70 11 13 591 593 B-upper_bound

Any 0 3 594 597 O
other 4 9 598 603 O
condition 10 19 604 613 O
or 20 22 614 616 O
therapy 23 30 617 624 B-treatment
that 31 35 625 629 O
, 35 36 629 630 O
in 37 39 631 633 O
the 40 43 634 637 O
investigator 44 56 638 650 O
's 56 58 650 652 O
opinion 59 66 653 660 O
, 66 67 660 661 O
may 68 71 662 665 O
pose 72 76 666 670 O
a 77 78 671 672 O
risk 79 83 673 677 O
to 84 86 678 680 O
the 87 90 681 684 O
subject 91 98 685 692 O
, 98 99 692 693 O
prevent 100 107 694 701 O
the 108 111 702 705 O
subject 112 119 706 713 O
from 120 124 714 718 O
completing 125 135 719 729 O
the 136 139 730 733 O
required 140 148 734 742 O
study 149 154 743 748 O
procedures 155 165 749 759 O
or 166 168 760 762 O
interfere 169 178 763 772 O
with 179 183 773 777 O
the 184 187 778 781 O
study 188 193 782 787 O
objectives 194 204 788 798 O
• 205 206 799 800 O
Less 207 211 801 805 O
than 212 216 806 810 O
75 217 219 811 813 B-upper_bound
% 219 220 813 814 I-upper_bound
European 221 229 815 823 B-ethnicity
ancestry 230 238 824 832 I-ethnicity
proportions 239 250 833 844 O
or 251 253 845 847 O
African 254 261 848 855 B-ethnicity
- 261 262 855 856 I-ethnicity
American 262 270 856 864 I-ethnicity
ancestry 271 279 865 873 I-ethnicity
porportions 280 291 874 885 O

As 0 2 886 888 O
of 3 5 889 891 O
Screen 6 12 892 898 O
Visit 13 18 899 904 O
, 18 19 904 905 O
the 20 23 906 909 O
subject 24 31 910 917 O
is 32 34 918 920 O
sharing 35 42 921 928 O
a 43 44 929 930 O
household 45 54 931 940 O
with 55 59 941 945 O
a 60 61 946 947 O
subject 62 69 948 955 O
randomized 70 80 956 966 O
to 81 83 967 969 O
any 84 87 970 973 O
investigational 88 103 974 989 O
trial 104 109 990 995 O
of 110 112 996 998 O
ondansetron 113 124 999 1010 B-treatment

At 0 2 1011 1013 O
the 3 6 1014 1017 O
Screen 7 13 1018 1024 O
Visit 14 19 1025 1030 O
, 19 20 1030 1031 O
the 21 24 1032 1035 O
subject 25 32 1036 1043 O
's 32 34 1043 1045 O
urine 35 40 1046 1051 O
contains 41 49 1052 1060 O
opiates 50 57 1061 1068 B-treatment
, 57 58 1068 1069 O
cocaine 59 66 1070 1077 B-treatment
, 66 67 1077 1078 O
amphetamines 68 80 1079 1091 B-treatment
, 80 81 1091 1092 O
barbiturates 82 94 1093 1105 B-treatment
, 94 95 1105 1106 O
or 96 98 1107 1109 O
benzodiazepines 99 114 1110 1125 B-treatment
that 115 119 1126 1130 O
can 120 123 1131 1134 O
not 123 126 1134 1137 O
be 127 129 1138 1140 O
explained 130 139 1141 1150 O
by 140 142 1151 1153 O
appropriate 143 154 1154 1165 O
use 155 158 1166 1169 O
of 159 161 1170 1172 O
prescribed 162 172 1173 1183 O
medication 173 183 1184 1194 B-treatment

Body 0 4 1195 1199 B-clinical_variable
weight 5 11 1200 1206 I-clinical_variable
greater 12 19 1207 1214 O
than 20 24 1215 1219 O
or 25 27 1220 1222 O
equal 28 33 1223 1228 O
to 34 36 1229 1231 O
110 37 40 1232 1235 B-lower_bound
kg 41 43 1236 1238 I-lower_bound
( 44 45 1239 1240 O
242 45 48 1240 1243 B-upper_bound
lb 49 51 1244 1246 I-upper_bound
) 51 52 1246 1247 O

Clinically 0 10 1248 1258 O
significant 11 22 1259 1270 O
abnormal 23 31 1271 1279 O
12 32 34 1280 1282 B-treatment
- 34 35 1282 1283 I-treatment
lead 35 39 1283 1287 I-treatment
ECG 40 43 1288 1291 I-treatment
at 44 46 1292 1294 O
the 47 50 1295 1298 O
Screen 51 57 1299 1305 O
Visit 58 63 1306 1311 O
, 63 64 1311 1312 O
clinically 65 75 1313 1323 O
significant 76 87 1324 1335 O
cardiovascular 88 102 1336 1350 B-chronic_disease
disease 103 110 1351 1358 I-chronic_disease
requiring 111 120 1359 1368 O
regular 121 128 1369 1376 O
or 129 131 1377 1379 O
intensive 132 141 1380 1389 O
clinical 142 150 1390 1398 O
monitoring 151 161 1399 1409 O

Clinically 0 10 1410 1420 O
significant 11 22 1421 1432 O
, 22 23 1432 1433 O
unstable 24 32 1434 1442 O
physical 33 41 1443 1451 B-chronic_disease
illness 42 49 1452 1459 I-chronic_disease
( 50 51 1460 1461 O
e.g. 51 55 1461 1465 O
, 55 56 1465 1466 O
hematologic 57 68 1467 1478 B-chronic_disease
, 68 69 1478 1479 O
hepatic 70 77 1480 1487 B-chronic_disease
or 78 80 1488 1490 O
renal 81 86 1491 1496 B-chronic_disease
insufficiency 87 100 1497 1510 I-chronic_disease
, 100 101 1510 1511 O
or 102 104 1512 1514 O
a 105 106 1515 1516 O
cardiovascular 107 121 1517 1531 B-chronic_disease
, 121 122 1531 1532 O
pulmonary 123 132 1533 1542 B-chronic_disease
, 132 133 1542 1543 O
gastrointestinal 134 150 1544 1560 B-chronic_disease
, 150 151 1560 1561 O
endocrine 152 161 1562 1571 B-chronic_disease
, 161 162 1571 1572 O
neurological 163 175 1573 1585 B-chronic_disease
, 175 176 1585 1586 O
infectious 177 187 1587 1597 B-chronic_disease
, 187 188 1597 1598 O
neoplastic 189 199 1599 1609 B-chronic_disease
, 199 200 1609 1610 O
or 201 203 1611 1613 O
metabolic 204 213 1614 1623 B-chronic_disease
disturbance 214 225 1624 1635 I-chronic_disease
) 225 226 1635 1636 O

Clinically 0 10 1637 1647 O
unstable 11 19 1648 1656 O
cardiac 20 27 1657 1664 B-chronic_disease
disease 28 35 1665 1672 I-chronic_disease
, 35 36 1672 1673 O
including 37 46 1674 1683 O
unstable 47 55 1684 1692 O
atrial 56 62 1693 1699 B-chronic_disease
fibrillation 63 75 1700 1712 I-chronic_disease
, 75 76 1712 1713 O
symptomatic 77 88 1714 1725 B-chronic_disease
bradycardia 89 100 1726 1737 I-chronic_disease
, 100 101 1737 1738 O
unstable 102 110 1739 1747 O
congestive 111 121 1748 1758 B-chronic_disease
heart 122 127 1759 1764 I-chronic_disease
failure 128 135 1765 1772 I-chronic_disease
, 135 136 1772 1773 O
active 137 143 1774 1780 O
myocardial 144 154 1781 1791 B-chronic_disease
ischemia 155 163 1792 1800 I-chronic_disease
or 164 166 1801 1803 O
indwelling 167 177 1804 1814 O
cardiac 178 185 1815 1822 B-treatment
pacemaker 186 195 1823 1832 I-treatment

Complete 0 8 1833 1841 O
left 9 13 1842 1846 B-chronic_disease
bundle 14 20 1847 1853 I-chronic_disease
branch 21 27 1854 1860 I-chronic_disease
block 28 33 1861 1866 I-chronic_disease

Current 0 7 1867 1874 O
or 8 10 1875 1877 O
recent 11 17 1878 1884 O
( 18 19 1885 1886 O
within 19 25 1886 1892 O
4 26 27 1893 1894 B-upper_bound
weeks 28 33 1895 1900 I-upper_bound
prior 34 39 1901 1906 I-upper_bound
to 40 42 1907 1909 O
Baseline 43 51 1910 1918 O
Visit 52 57 1919 1924 O
) 57 58 1924 1925 O
treatment 59 68 1926 1935 B-treatment
with 69 73 1936 1940 I-treatment
antipsychotics 74 88 1941 1955 I-treatment
or 89 91 1956 1958 O
any 92 95 1959 1962 O
medication 96 106 1963 1973 B-treatment
likely 107 113 1974 1980 O
to 114 116 1981 1983 O
interact 117 125 1984 1992 O
with 126 130 1993 1997 O
ondansetron 131 142 1998 2009 B-treatment
to 143 145 2010 2012 O
produce 146 153 2013 2020 O
an 154 156 2021 2023 O
adverse 157 164 2024 2031 O
effect 165 171 2032 2038 O
, 171 172 2038 2039 O
as 173 175 2040 2042 O
judged 176 182 2043 2049 O
by 183 185 2050 2052 O
a 186 187 2053 2054 O
study 188 193 2055 2060 O
physician 194 203 2061 2070 O

Currently 0 9 2071 2080 O
participating 10 23 2081 2094 O
or 24 26 2095 2097 O
has 27 30 2098 2101 O
recently 31 39 2102 2110 O
( 40 41 2111 2112 O
4 41 42 2112 2113 B-upper_bound
weeks 43 48 2114 2119 I-upper_bound
prior 49 54 2120 2125 I-upper_bound
to 55 57 2126 2128 O
Randomization 58 71 2129 2142 O
) 71 72 2142 2143 O
participated 73 85 2144 2156 O
in 86 88 2157 2159 O
a 89 90 2160 2161 O
treatment 91 100 2162 2171 B-treatment
program 101 108 2172 2179 I-treatment
for 109 112 2180 2183 O
alcohol 113 120 2184 2191 B-chronic_disease
use 121 124 2192 2195 I-chronic_disease
disorders 125 134 2196 2205 I-chronic_disease

Diagnosis 0 9 2206 2215 O
of 10 12 2216 2218 O
alcohol 13 20 2219 2226 B-chronic_disease
use 21 24 2227 2230 I-chronic_disease
disorder 25 33 2231 2239 I-chronic_disease
( 34 35 2240 2241 I-chronic_disease
AUD 35 38 2241 2244 I-chronic_disease
) 38 39 2244 2245 I-chronic_disease
using 40 45 2246 2251 O
Diagnostic 46 56 2252 2262 O
and 57 60 2263 2266 O
Statistical 61 72 2267 2278 O
Manual 73 79 2279 2285 O
of 80 82 2286 2288 O
Mental 83 89 2289 2295 O
Disorders 90 99 2296 2305 O
, 99 100 2305 2306 O
5th 101 104 2307 2310 O
Edition 105 112 2311 2318 O
( 113 114 2319 2320 O
DSM-5 114 119 2320 2325 O
) 119 120 2325 2326 O
criteria 121 129 2327 2335 O

Evidence 0 8 2336 2344 O
of 9 11 2345 2347 O
hepatic 12 19 2348 2355 O
failure 20 27 2356 2363 O
and/or 28 34 2364 2370 O
ascites 35 42 2371 2378 O
, 42 43 2378 2379 O
prolonged 44 53 2380 2389 B-clinical_variable
prothrombin 54 65 2390 2401 I-clinical_variable
time 66 70 2402 2406 I-clinical_variable
( 71 72 2407 2408 O
International 72 85 2408 2421 B-clinical_variable
Normalized 86 96 2422 2432 I-clinical_variable
Ratio 97 102 2433 2438 I-clinical_variable
[ 103 104 2439 2440 I-clinical_variable
INR 104 107 2440 2443 I-clinical_variable
] 107 108 2443 2444 I-clinical_variable
> 109 110 2445 2446 O
or 111 113 2447 2449 O
= 114 115 2450 2451 O
1.7 116 119 2452 2455 B-lower_bound
) 119 120 2455 2456 O
, 120 121 2456 2457 O
bilirubin 122 131 2458 2467 B-clinical_variable
> 132 133 2468 2469 O
10 133 135 2469 2471 B-lower_bound
% 135 136 2471 2472 I-lower_bound
above 137 142 2473 2478 O
the 143 146 2479 2482 O
upper 147 152 2483 2488 O
limit 153 158 2489 2494 O
of 159 161 2495 2497 O
the 162 165 2498 2501 O
central 166 173 2502 2509 O
lab 174 177 2510 2513 O
's 177 179 2513 2515 O
normal 180 186 2516 2522 O
range 187 192 2523 2528 O
and/or 193 199 2529 2535 O
esophageal 200 210 2536 2546 B-chronic_disease
variceal 211 219 2547 2555 I-chronic_disease
disease 220 227 2556 2563 I-chronic_disease

Female 0 6 2564 2570 B-gender
subjects 7 15 2571 2579 I-gender
of 16 18 2580 2582 O
childbearing 19 31 2583 2595 O
potential 32 41 2596 2605 O
who 42 45 2606 2609 O
have 46 50 2610 2614 O
a 51 52 2615 2616 O
positive 53 61 2617 2625 B-pregnancy
pregnancy 62 71 2626 2635 I-pregnancy
test 72 76 2636 2640 O
at 77 79 2641 2643 O
Baseline 80 88 2644 2652 O
Visit 89 94 2653 2658 O
or 95 97 2659 2661 O
are 98 101 2662 2665 B-pregnancy
pregnant 102 110 2666 2674 I-pregnancy
, 110 111 2674 2675 O
breast 112 118 2676 2682 O
feeding 119 126 2683 2690 O
, 126 127 2690 2691 O
not 128 131 2692 2695 O
adhering 132 140 2696 2704 O
to 141 143 2705 2707 O
an 144 146 2708 2710 O
acceptable 147 157 2711 2721 O
form 158 162 2722 2726 O
of 163 165 2727 2729 O
contraception 166 179 2730 2743 O
at 180 182 2744 2746 O
screening 183 192 2747 2756 O
or 193 195 2757 2759 O
any 196 199 2760 2763 O
time 200 204 2764 2768 O
during 205 211 2769 2775 O
the 212 215 2776 2779 O
study 216 221 2780 2785 O
, 221 222 2785 2786 O
or 223 225 2787 2789 O
unwilling 226 235 2790 2799 B-contraception_consent
to 236 238 2800 2802 I-contraception_consent
maintain 239 247 2803 2811 I-contraception_consent
an 248 250 2812 2814 I-contraception_consent
acceptable 251 261 2815 2825 I-contraception_consent
form 262 266 2826 2830 I-contraception_consent
of 267 269 2831 2833 I-contraception_consent
contraception 270 283 2834 2847 I-contraception_consent
throughout 284 294 2848 2858 O
the 295 298 2859 2862 O
study 299 304 2863 2868 O

History 0 7 2869 2876 O
of 8 10 2877 2879 O
Long 11 15 2880 2884 B-chronic_disease
QT 16 18 2885 2887 I-chronic_disease
Syndrome 19 27 2888 2896 I-chronic_disease
or 28 30 2897 2899 O
a 31 32 2900 2901 O
first 33 38 2902 2907 O
- 38 39 2907 2908 O
degree 39 45 2908 2914 O
biological 46 56 2915 2925 O
family 57 63 2926 2932 O
member 64 70 2933 2939 O
with 71 75 2940 2944 O
this 76 80 2945 2949 O
condition 81 90 2950 2959 O

History 0 7 2960 2967 O
of 8 10 2968 2970 O
severe 11 17 2971 2977 O
or 18 20 2978 2980 O
life 21 25 2981 2985 O
- 25 26 2985 2986 O
threatening 26 37 2986 2997 O
adverse 38 45 2998 3005 O
reactions 46 55 3006 3015 O
to 56 58 3016 3018 O
ondansetron 59 70 3019 3030 B-allergy_name

Men 0 3 3031 3034 B-gender

Prior 0 5 3035 3040 O
to 6 8 3041 3043 O
Randomization 9 22 3044 3057 O
, 22 23 3057 3058 O
the 24 27 3059 3062 O
subject 28 35 3063 3070 O
is 36 38 3071 3073 O
compelled 39 48 3074 3083 O
to 49 51 3084 3086 O
participate 52 63 3087 3098 O
in 64 66 3099 3101 O
an 67 69 3102 3104 O
alcohol 70 77 3105 3112 O
treatment 78 87 3113 3122 B-treatment
program 88 95 3123 3130 O
to 96 98 3131 3133 O
maintain 99 107 3134 3142 O
his 108 111 3143 3146 O
/ 111 112 3146 3147 O
her 112 115 3147 3150 O
liberty 116 123 3151 3158 O

Provides 0 8 3159 3167 O
contact 9 16 3168 3175 O
information 17 28 3176 3187 O
for 29 32 3188 3191 O
1 33 34 3192 3193 B-lower_bound
or 35 37 3194 3196 O
2 38 39 3197 3198 B-upper_bound
locators 40 48 3199 3207 O
who 49 52 3208 3211 O
can 53 56 3212 3215 O
be 57 59 3216 3218 O
used 60 64 3219 3223 O
to 65 67 3224 3226 O
contact 68 75 3227 3234 O
the 76 79 3235 3238 O
subject 80 87 3239 3246 O

Stable 0 6 3247 3253 O
residence 7 16 3254 3263 O
in 17 19 3264 3266 O
the 20 23 3267 3270 O
28 24 26 3271 3273 B-upper_bound
days 27 31 3274 3278 I-upper_bound
prior 32 37 3279 3284 I-upper_bound
to 38 40 3285 3287 O
the 41 44 3288 3291 O
Baseline 45 53 3292 3300 O
Visit 54 59 3301 3306 O
and 60 63 3307 3310 O
no 64 66 3311 3313 O
plans 67 72 3314 3319 O
to 73 75 3320 3322 O
move 76 80 3323 3327 O
in 81 83 3328 3330 O
the 84 87 3331 3334 O
next 88 92 3335 3339 B-upper_bound
9 93 94 3340 3341 I-upper_bound
months 95 101 3342 3348 I-upper_bound

Subjects 0 8 3349 3357 O
who 9 12 3358 3361 O
are 13 16 3362 3365 O
deemed 17 23 3366 3372 O
by 24 26 3373 3375 O
the 27 30 3376 3379 O
PI 31 33 3380 3382 O
or 34 36 3383 3385 O
designee 37 45 3386 3394 O
to 46 48 3395 3397 O
be 49 51 3398 3400 O
at 52 54 3401 3403 O
risk 55 59 3404 3408 O
of 60 62 3409 3411 O
suicide 63 70 3412 3419 B-chronic_disease

Taking 0 6 3420 3426 O
medications 7 18 3427 3438 B-treatment
( 19 20 3439 3440 O
within 20 26 3440 3446 O
the 27 30 3447 3450 O
last 31 35 3451 3455 B-upper_bound
7 36 37 3456 3457 I-upper_bound
days 38 42 3458 3462 I-upper_bound
prior 43 48 3463 3468 I-upper_bound
to 49 51 3469 3471 O
the 52 55 3472 3475 O
Baseline 56 64 3476 3484 O
Visit 65 70 3485 3490 O
) 70 71 3490 3491 O
that 72 76 3492 3496 O
have 77 81 3497 3501 O
the 82 85 3502 3505 O
potential 86 95 3506 3515 O
to 96 98 3516 3518 O
prolong 99 106 3519 3526 O
the 107 110 3527 3530 O
QT 111 113 3531 3533 B-clinical_variable
interval 114 122 3534 3542 I-clinical_variable
, 122 123 3542 3543 O
as 124 126 3544 3546 O
judged 127 133 3547 3553 O
by 134 136 3554 3556 O
a 137 138 3557 3558 O
study 139 144 3559 3564 O
physician 145 154 3565 3574 O
, 154 155 3574 3575 O
or 156 158 3576 3578 O
may 159 162 3579 3582 O
require 163 170 3583 3590 O
such 171 175 3591 3595 O
medications 176 187 3596 3607 O
during 188 194 3608 3614 O
the 195 198 3615 3618 O
course 199 205 3619 3625 O
of 206 208 3626 3628 O
the 209 212 3629 3632 O
study 213 218 3633 3638 O

The 0 3 3639 3642 O
subject 4 11 3643 3650 O
has 12 15 3651 3654 O
a 16 17 3655 3656 O
Clinical 18 26 3657 3665 B-clinical_variable
Institute 27 36 3666 3675 I-clinical_variable
Withdrawal 37 47 3676 3686 I-clinical_variable
Assessment 48 58 3687 3697 I-clinical_variable
for 59 62 3698 3701 I-clinical_variable
Alcohol 63 70 3702 3709 I-clinical_variable
Scale 71 76 3710 3715 I-clinical_variable
( 77 78 3716 3717 I-clinical_variable
CIWA 78 82 3717 3721 I-clinical_variable
- 82 83 3721 3722 I-clinical_variable
Ar 83 85 3722 3724 I-clinical_variable
) 85 86 3724 3725 I-clinical_variable
, 86 87 3725 3726 I-clinical_variable
Revised 88 95 3727 3734 I-clinical_variable
, 95 96 3734 3735 I-clinical_variable
score 97 102 3736 3741 I-clinical_variable
≥10 103 106 3742 3745 O

The 0 3 3746 3749 O
subject 4 11 3750 3757 O
has 12 15 3758 3761 O
a 16 17 3762 3763 O
breath 18 24 3764 3770 B-clinical_variable
alcohol 25 32 3771 3778 I-clinical_variable
concentration 33 46 3779 3792 I-clinical_variable
( 47 48 3793 3794 I-clinical_variable
BrAC 48 52 3794 3798 I-clinical_variable
) 52 53 3798 3799 I-clinical_variable
= 54 55 3800 3801 O
0.00 56 60 3802 3806 O
% 60 61 3806 3807 O
at 62 64 3808 3810 O
the 65 68 3811 3814 O
screening 69 78 3815 3824 O
visit 79 84 3825 3830 O
and 85 88 3831 3834 O
< 89 90 3835 3836 O
or 91 93 3837 3839 O
= 94 95 3840 3841 O
0.02 96 100 3842 3846 B-upper_bound
% 100 101 3846 3847 I-upper_bound
at 102 104 3848 3850 O
all 105 108 3851 3854 O
visits 109 115 3855 3861 O
after 116 121 3862 3867 O
the 122 125 3868 3871 O
screening 126 135 3872 3881 O
visit 136 141 3882 3887 O

The 0 3 3888 3891 O
subject 4 11 3892 3899 O
has 12 15 3900 3903 O
a 16 17 3904 3905 O
current 18 25 3906 3913 O
diagnosis 26 35 3914 3923 O
of 36 38 3924 3926 O
schizophrenia 39 52 3927 3940 B-chronic_disease
, 52 53 3940 3941 O
bipolar 54 61 3942 3949 B-chronic_disease
disorder 62 70 3950 3958 I-chronic_disease
, 70 71 3958 3959 O
or 72 74 3960 3962 O
other 75 80 3963 3968 O
psychotic 81 90 3969 3978 B-chronic_disease
disorder 91 99 3979 3987 I-chronic_disease
, 99 100 3987 3988 O
or 101 103 3989 3991 O
a 104 105 3992 3993 O
non 106 109 3994 3997 O
- 109 110 3997 3998 O
psychotic 110 119 3998 4007 O
diagnosis 120 129 4008 4017 O
such 130 134 4018 4022 O
as 135 137 4023 4025 O
major 138 143 4026 4031 B-chronic_disease
depressive 144 154 4032 4042 I-chronic_disease
disorder 155 163 4043 4051 I-chronic_disease
, 163 164 4051 4052 O
post 165 169 4053 4057 B-chronic_disease
- 169 170 4057 4058 I-chronic_disease
traumatic 170 179 4058 4067 I-chronic_disease
stress 180 186 4068 4074 I-chronic_disease
disorder 187 195 4075 4083 I-chronic_disease
, 195 196 4083 4084 O
panic 197 202 4085 4090 B-chronic_disease
disorder 203 211 4091 4099 I-chronic_disease
, 211 212 4099 4100 O
eating 213 219 4101 4107 B-chronic_disease
disorder 220 228 4108 4116 I-chronic_disease
, 228 229 4116 4117 O
or 230 232 4118 4120 O
substance 233 242 4121 4130 O
use 243 246 4131 4134 O
disorder 247 255 4135 4143 O

The 0 3 4144 4147 O
subject 4 11 4148 4155 O
has 12 15 4156 4159 O
fewer 16 21 4160 4165 O
than 22 26 4166 4170 O
6 27 28 4171 4172 B-upper_bound
heavy 29 34 4173 4178 O
drinking 35 43 4179 4187 O
days 44 48 4188 4192 O
( 49 50 4193 4194 O
HDD 50 53 4194 4197 O
) 53 54 4197 4198 O
( 55 56 4199 4200 O
defined 56 63 4200 4207 O
as 64 66 4208 4210 O
≥5 67 69 4211 4213 O
standard 70 78 4214 4222 O
drinks 79 85 4223 4229 O
for 86 89 4230 4233 O
men 90 93 4234 4237 B-gender
and 94 97 4238 4241 O
≥4 98 100 4242 4244 O
or 101 103 4245 4247 O
greater 104 111 4248 4255 O
standard 112 120 4256 4264 O
drinks 121 127 4265 4271 O
for 128 131 4272 4275 O
women 132 137 4276 4281 B-gender
) 137 138 4281 4282 O
in 139 141 4283 4285 O
the 142 145 4286 4289 O
4 146 147 4290 4291 B-upper_bound
weeks 148 153 4292 4297 I-upper_bound
preceding 154 163 4298 4307 I-upper_bound
the 164 167 4308 4311 O
Baseline 168 176 4312 4320 O
Visit 177 182 4321 4326 O

The 0 3 4327 4330 O
subject 4 11 4331 4338 O
has 12 15 4339 4342 O
greater 16 23 4343 4350 O
than 24 28 4351 4355 O
14 29 31 4356 4358 B-lower_bound
consecutive 32 43 4359 4370 O
abstinent 44 53 4371 4380 O
days 54 58 4381 4385 O
in 59 61 4386 4388 O
the 62 65 4389 4392 O
4 66 67 4393 4394 B-upper_bound
weeks 68 73 4395 4400 I-upper_bound
preceding 74 83 4401 4410 O
the 84 87 4411 4414 O
Baseline 88 96 4415 4423 O
Visit 97 102 4424 4429 O

Treatment 0 9 4430 4439 B-treatment
with 10 14 4440 4444 I-treatment
any 15 18 4445 4448 I-treatment
investigational 19 34 4449 4464 I-treatment
medicinal 35 44 4465 4474 I-treatment
product 45 52 4475 4482 I-treatment
within 53 59 4483 4489 O
30 60 62 4490 4492 B-upper_bound
days 63 67 4493 4497 I-upper_bound
or 68 70 4498 4500 O
5 71 72 4501 4502 B-upper_bound
half 73 77 4503 4507 O
- 77 78 4507 4508 O
lives 78 83 4508 4513 O
( 84 85 4514 4515 O
whichever 85 94 4515 4524 O
is 95 97 4525 4527 O
longer 98 104 4528 4534 O
) 104 105 4534 4535 O
prior 106 111 4536 4541 O
to 112 114 4542 4544 O
Randomization 115 128 4545 4558 O

Treatment 0 9 4559 4568 B-treatment
, 9 10 4568 4569 O
either 11 17 4570 4576 O
current 18 25 4577 4584 O
or 26 28 4585 4587 O
within 29 35 4588 4594 O
28 36 38 4595 4597 B-upper_bound
days 39 43 4598 4602 I-upper_bound
prior 44 49 4603 4608 I-upper_bound
to 50 52 4609 4611 O
Randomization 53 66 4612 4625 O
, 66 67 4625 4626 O
with 68 72 4627 4631 O
any 73 76 4632 4635 O
medications 77 88 4636 4647 B-treatment
having 89 95 4648 4654 O
a 96 97 4655 4656 O
potential 98 107 4657 4666 O
effect 108 114 4667 4673 O
on 115 117 4674 4676 O
alcohol 118 125 4677 4684 O
consumption 126 137 4685 4696 O
and 138 141 4697 4700 O
related 142 149 4701 4708 O
behaviors 150 159 4709 4718 O
or 160 162 4719 4721 O
mood 163 167 4722 4726 O
. 167 168 4726 4727 O
These 169 174 4728 4733 O
include 175 182 4734 4741 O
opioid 183 189 4742 4748 O
antagonists 190 201 4749 4760 O
( 202 203 4761 4762 O
e.g. 203 207 4762 4766 O
, 207 208 4766 4767 O
naltrexone 209 219 4768 4778 B-treatment
, 219 220 4778 4779 O
Vivitrol 221 229 4780 4788 B-treatment
® 229 230 4788 4789 I-treatment
, 230 231 4789 4790 O
Selincro 232 240 4791 4799 B-treatment
® 240 241 4799 4800 I-treatment
) 241 242 4800 4801 O
, 242 243 4801 4802 O
glutamate 244 253 4803 4812 B-treatment
antagonists 254 265 4813 4824 I-treatment
( 266 267 4825 4826 O
e.g. 267 271 4826 4830 O
, 271 272 4830 4831 O
acamprosate 273 284 4832 4843 B-treatment
) 284 285 4843 4844 O
, 285 286 4844 4845 O
anticonvulsants 287 302 4846 4861 B-treatment
( 303 304 4862 4863 O
e.g. 304 308 4863 4867 O
, 308 309 4867 4868 O
topiramate 310 320 4869 4879 B-treatment
, 320 321 4879 4880 O
gabapentin 322 332 4881 4891 B-treatment
) 332 333 4891 4892 O
, 333 334 4892 4893 O
serotonin 335 344 4894 4903 B-treatment
reuptake 345 353 4904 4912 I-treatment
inhibitors 354 364 4913 4923 I-treatment
( 365 366 4924 4925 O
e.g. 366 370 4925 4929 O
, 370 371 4929 4930 O
fluoxetine 372 382 4931 4941 B-treatment
) 382 383 4941 4942 O
, 383 384 4942 4943 O
serotonin 385 394 4944 4953 B-treatment
antagonists 395 406 4954 4965 I-treatment
( 407 408 4966 4967 O
e.g. 408 412 4967 4971 O
, 412 413 4971 4972 O
buspirone 414 423 4973 4982 B-treatment
) 423 424 4982 4983 O
, 424 425 4983 4984 O
other 426 431 4985 4990 O
antidepressants 432 447 4991 5006 B-treatment
( 448 449 5007 5008 O
e.g. 449 453 5008 5012 O
, 453 454 5012 5013 O
tricyclic 455 464 5014 5023 B-treatment
antidepressants 465 480 5024 5039 I-treatment
or 481 483 5040 5042 O
monoamine 484 493 5043 5052 B-treatment
oxidase 494 501 5053 5060 B-treatment
inhibitors 502 512 5061 5071 I-treatment
) 512 513 5071 5072 O
, 513 514 5072 5073 O
dopamine 515 523 5074 5082 B-treatment
antagonists 524 535 5083 5094 I-treatment
( 536 537 5095 5096 O
e.g. 537 541 5096 5100 O
, 541 542 5100 5101 O
haloperidol 543 554 5102 5113 B-treatment
) 554 555 5113 5114 O
, 555 556 5114 5115 O
and 557 560 5116 5119 O
disulfiram 561 571 5120 5130 B-treatment
( 572 573 5131 5132 O
Antabuse 573 581 5132 5140 B-treatment
® 581 582 5140 5141 I-treatment
) 582 583 5141 5142 O

Willingness 0 11 5143 5154 O
to 12 14 5155 5157 O
participate 15 26 5158 5169 O
in 27 29 5170 5172 O
behavioral 30 40 5173 5183 O
and 41 44 5184 5187 O
medicinal 45 54 5188 5197 O
treatments 55 65 5198 5208 B-treatment
for 66 69 5209 5212 O
Alcohol 70 77 5213 5220 O
Use 78 81 5221 5224 O
Disorder 82 90 5225 5233 O

current 0 7 5234 5241 O
history 8 15 5242 5249 O
of 16 18 5250 5252 O
arrhythmias 19 30 5253 5264 B-chronic_disease

current 0 7 5265 5272 O
or 8 10 5273 5275 O
past 11 15 5276 5280 O
history 16 23 5281 5288 O
of 24 26 5289 5291 O
clinically 27 37 5292 5302 O
significant 38 49 5303 5314 O
QT 50 52 5315 5317 O
prolongation 53 65 5318 5330 O
, 65 66 5330 5331 O
including 67 76 5332 5341 O
: 76 77 5341 5342 O
QTcF 78 82 5343 5347 B-clinical_variable
> 83 84 5348 5349 O
450 85 88 5350 5353 B-lower_bound
ms 89 91 5354 5356 I-lower_bound
( 92 93 5357 5358 O
average 93 100 5358 5365 O
of 101 103 5366 5368 O
3 104 105 5369 5370 B-lower_bound
12 106 108 5371 5373 B-clinical_variable
- 108 109 5373 5374 I-clinical_variable
lead 109 113 5374 5378 I-clinical_variable
measurements 114 126 5379 5391 I-clinical_variable
) 126 127 5391 5392 O

women 0 5 5393 5398 B-gender

